Free Trial

Nutex Health (NASDAQ:NUTX) Stock Price Expected to Rise, Maxim Group Analyst Says

Nutex Health logo with Medical background

Nutex Health (NASDAQ:NUTX - Free Report) had its price target hoisted by Maxim Group from $50.00 to $75.00 in a research note issued to investors on Thursday,Benzinga reports. The firm currently has a buy rating on the stock.

Separately, Benchmark raised their price objective on shares of Nutex Health from $45.00 to $60.00 and gave the company a "buy" rating in a report on Tuesday, November 12th.

View Our Latest Research Report on NUTX

Nutex Health Stock Down 1.9 %

Nutex Health stock traded down $1.30 during mid-day trading on Thursday, reaching $66.06. 36,755 shares of the company's stock were exchanged, compared to its average volume of 42,467. The company has a market cap of $359.17 million, a P/E ratio of -7.04 and a beta of 0.20. Nutex Health has a twelve month low of $4.16 and a twelve month high of $69.45. The company has a quick ratio of 1.74, a current ratio of 1.77 and a debt-to-equity ratio of 3.36. The company has a fifty day moving average of $40.18 and a 200-day moving average of $29.45.

Institutional Investors Weigh In On Nutex Health

A number of hedge funds and other institutional investors have recently modified their holdings of NUTX. Topline Capital Management LLC acquired a new stake in shares of Nutex Health in the 4th quarter valued at $5,690,000. American Century Companies Inc. acquired a new stake in shares of Nutex Health in the 4th quarter valued at $1,362,000. Ancora Advisors LLC purchased a new position in shares of Nutex Health in the 4th quarter valued at $1,334,000. Drive Wealth Management LLC purchased a new position in shares of Nutex Health in the 4th quarter valued at $1,122,000. Finally, Essex Investment Management Co. LLC grew its position in shares of Nutex Health by 45.4% in the 4th quarter. Essex Investment Management Co. LLC now owns 105,809 shares of the company's stock valued at $3,353,000 after buying an additional 33,024 shares during the last quarter. 5.32% of the stock is currently owned by institutional investors and hedge funds.

About Nutex Health

(Get Free Report)

Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.

Featured Stories

Should You Invest $1,000 in Nutex Health Right Now?

Before you consider Nutex Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nutex Health wasn't on the list.

While Nutex Health currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA Earnings: Will it Spark a Rally or Trigger a Sell-Off?
Marjorie Taylor Greene Bought THOUSANDS in Tesla Stock
The EXACT Date of Next Stock Market Crash

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines